These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 23740364)

  • 41. An analysis of the lowest effective intensity of prophylactic anticoagulation for patients with nonrheumatic atrial fibrillation.
    Hylek EM; Skates SJ; Sheehan MA; Singer DE
    N Engl J Med; 1996 Aug; 335(8):540-6. PubMed ID: 8678931
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Pre-admission warfarin use in patients with acute ischemic stroke and atrial fibrillation: The appropriate use and barriers to oral anticoagulant therapy.
    Partington SL; Abid S; Teo K; Oczkowski W; O'Donnell MJ
    Thromb Res; 2007; 120(5):663-9. PubMed ID: 17434577
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Relationship between platelet indices and international normalized ratio in patients with non-valvular atrial fibrillation.
    Arık OZ; Ozkan B; Kutlu R; Karal H; Sahin DY; Kaypaklı O; Ozel D; Cayli M
    Platelets; 2014; 25(5):311-6. PubMed ID: 23971881
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effect of fixed minidose warfarin, conventional dose warfarin and aspirin on INR and prothrombin fragment 1 + 2 in patients with atrial fibrillation.
    Koefoed BG; Feddersen C; Gulløv AL; Petersen P
    Thromb Haemost; 1997 May; 77(5):845-8. PubMed ID: 9184390
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The lowest effective intensity of prophylactic anticoagulation for patients with atrial fibrillation.
    Cheung CM; Tsoi TH; Huang CY
    Cerebrovasc Dis; 2005; 20(2):114-9. PubMed ID: 16006759
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Short-term clinical outcome after acute symptomatic pulmonary embolism.
    Conget F; Otero R; Jiménez D; Martí D; Escobar C; Rodríguez C; Uresandi F; Cabezudo MA; Nauffal D; Oribe M; Yusen R
    Thromb Haemost; 2008 Nov; 100(5):937-42. PubMed ID: 18989541
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Statin treatment and the risk of recurrent pulmonary embolism.
    Biere-Rafi S; Hutten BA; Squizzato A; Ageno W; Souverein PC; de Boer A; Gerdes VE; Büller HR; Kamphuisen PW
    Eur Heart J; 2013 Jun; 34(24):1800-6. PubMed ID: 23396492
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A comparison of two intensities of warfarin for the prevention of recurrent thrombosis in patients with the antiphospholipid antibody syndrome.
    Crowther MA; Ginsberg JS; Julian J; Denburg J; Hirsh J; Douketis J; Laskin C; Fortin P; Anderson D; Kearon C; Clarke A; Geerts W; Forgie M; Green D; Costantini L; Yacura W; Wilson S; Gent M; Kovacs MJ
    N Engl J Med; 2003 Sep; 349(12):1133-8. PubMed ID: 13679527
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Warfarin use and outcomes in patients with atrial fibrillation complicating acute coronary syndromes.
    Lopes RD; Starr A; Pieper CF; Al-Khatib SM; Newby LK; Mehta RH; Van de Werf F; Mahaffey KW; Armstrong PW; Harrington RA; White HD; Wallentin L; Granger CB
    Am J Med; 2010 Feb; 123(2):134-40. PubMed ID: 20103022
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Myocardial ischemic events in patients with atrial fibrillation treated with dabigatran or warfarin in the RE-LY (Randomized Evaluation of Long-Term Anticoagulation Therapy) trial.
    Hohnloser SH; Oldgren J; Yang S; Wallentin L; Ezekowitz M; Reilly P; Eikelboom J; Brueckmann M; Yusuf S; Connolly SJ
    Circulation; 2012 Feb; 125(5):669-76. PubMed ID: 22215856
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cardiac troponin testing and the simplified Pulmonary Embolism Severity Index. The SWIss Venous ThromboEmbolism Registry (SWIVTER).
    Spirk D; Aujesky D; Husmann M; Hayoz D; Baldi T; Frauchiger B; Banyai M; Baumgartner I; Kucher N
    Thromb Haemost; 2011 Nov; 106(5):978-84. PubMed ID: 21833454
    [TBL] [Abstract][Full Text] [Related]  

  • 52. In Potential Stroke Patients on Warfarin, the International Normalized Ratio Predicts Ischemia.
    Cao C; Martinelli A; Spoelhof B; Llinas RH; Marsh EB
    Cerebrovasc Dis Extra; 2017; 7(2):111-119. PubMed ID: 28803231
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Acute Pulmonary Embolism in Emergency Department Patients Despite Therapeutic Anticoagulation.
    Liu MY; Ballard DW; Huang J; Rauchwerger AS; Reed ME; Bouvet SC; Vinson DR
    West J Emerg Med; 2018 May; 19(3):510-516. PubMed ID: 29760849
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Anticoagulation management in individuals with hip fracture.
    Gleason LJ; Mendelson DA; Kates SL; Friedman SM
    J Am Geriatr Soc; 2014 Jan; 62(1):159-64. PubMed ID: 24383759
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effect of stress on international normalized ratio during warfarin therapy.
    Hawk TL; Havrda DE
    Ann Pharmacother; 2002 Apr; 36(4):617-20. PubMed ID: 11918508
    [TBL] [Abstract][Full Text] [Related]  

  • 56. INR variability and outcomes in patients with mechanical heart valve prosthesis.
    Labaf A; Själander A; Stagmo M; Svensson PJ
    Thromb Res; 2015 Dec; 136(6):1211-5. PubMed ID: 26558830
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Prognostic significance of free-floating right heart thromboemboli in acute pulmonary embolism: results from the Italian Pulmonary Embolism Registry.
    Casazza F; Becattini C; Guglielmelli E; Floriani I; Morrone V; Caponi C; Pizzorno L; Masotti L; Bongarzoni A; Pignataro L
    Thromb Haemost; 2014 Jan; 111(1):53-7. PubMed ID: 24085244
    [TBL] [Abstract][Full Text] [Related]  

  • 58. International Normalized Ratio and Mortality Risk in Acute Heart Failure and Nonvalvular Atrial Fibrillation Patients Receiving Vitamin K Antagonists.
    Santas E; Miñana G; Gummel J; Farcasan R; Payá A; Heredia R; Bodí V; Mollar A; Bertomeu-González V; Chorro FJ; Sanchis J; Lupón J; Bayés Genís A; Núñez J
    Rev Esp Cardiol (Engl Ed); 2019 Aug; 72(8):616-624. PubMed ID: 30201288
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Prognostic significance of deep vein thrombosis in patients presenting with acute symptomatic pulmonary embolism.
    Jiménez D; Aujesky D; Díaz G; Monreal M; Otero R; Martí D; Marín E; Aracil E; Sueiro A; Yusen RD;
    Am J Respir Crit Care Med; 2010 May; 181(9):983-91. PubMed ID: 20110556
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A descriptive evaluation of warfarin use in patients with pulmonary arterial hypertension.
    Irwin AN; Johnson SG; Joline BR; Delate T; Witt DM
    Thromb Res; 2014 May; 133(5):790-4. PubMed ID: 24642007
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.